🚨 New special issue now online 🚨
Read our latest special issue, which delves further into the different aspects surrounding #Vasculitis. The issue is freely available for everyone to read until next month.
Click here to read the full articles now ➡️ https://t.co/cuNRgs7SS1
CMRO is proud to be the host of the National Association of Specialty Pharmacy's Annual Meeting & Expo 2023 Abstracts for the third time! Read here: 👉👉👉👉https://t.co/67A6498J7w
I am delighted to announce the first cohort of our newly launched Early Career Panel. This initiative aims to provide opportunities for the members and increase the journals representation of the early career researcher community.
#earlycareerresearcher#pharmacoeconomics#HEOR
Elevated Lipoprotein(a) is the latest variant of ‘bad cholesterol’ found to increase the risk of recurrent coronary heart disease.
Findings, published by @UNSWMedicine researchers in @CMRO_Journal, show it is an important CHD predictor in people 60+⚠️
https://t.co/VEtJdEtW2b
ISPOR 2023, the leading global conference for health economics and outcomes research (#HEOR), May 7-10 at the Boston Convention & Exhibition Center, Boston, MA, USA. Hear the latest hot topics and trends in #HEOR. #ISPORAnnual
click the link for more 👉https://t.co/mCrgrlMmfD
🚨Abstracts presented on topics in cardiorenal and cardiometabolic health at #CMHC17thAnnual in Boston have been published in Postgraduate Medicine.
🔗Read more in the latest Press Release from CMHC: https://t.co/0HBZTgCBmt
#MedTwitter@postgradmed
We are excited to share this recent supplement with everyone, which highlights the abstracts from the 17th Annual Cardiometabolic Health Congress (@CMHC_CME).
Click here to read the full supplement online ➡️ https://t.co/iQmvAzScnI #Cardiometabolic#Cardiovascular#Diabetes
💥Register now💥 for this April 19th webinar brought to you by Taylor & Francis. This event is a must if you would like to avoid common publishing pitfalls, while learning how to publish highly impactful research articles. Sign up at https://t.co/UaAH7pSpom 👍 @tandfmedicine
Delighted to share a recent supplement, which has been published in Postgraduate Medicine, on "#Semaglutide for #weight management – an introduction for primary care."
Click here to read the full supplement ➡️ https://t.co/dIGxwbnpyK #WeightManagement#Obesity#PrimaryCare
Read our latest article on the “#Metaverse applied to #musculoskeletal pathology: Orthoverse and Rehabverse”, which has recently been published online.
Click here to view the article ➡️ https://t.co/boaCn5wvl6 #Orthoverse#Rehabverse
For those of you attending #PAINWeek 2022 this week, make sure you check out the #OpenAccess Abstracts presented from the conference in this dedicated Abstract book published with Postgraduate Medicine https://t.co/WVSFnoGzfH
Attending #PAINWeek? Check out our symposium to hear about a streamlined approach to identifying and treating patients with migraine on Tuesday, September 6, 2022, from 12:30 PM - 1:30 PM PST.
You can find it here: https://t.co/U9NJPcA6V1
Welcome to #PAINWeek 2022! Courses start Tuesday. Which 7:30am-8:40am topic will you choose?
—Newly Discovered #Cannabinoids
—Trash the Stash: Safe #Opioid Disposal
—#EatingDisorders and Chronic Pain
Full agenda here: https://t.co/COURLvIj2O
#painweek#CE/CME
Michael R McClung from @ACUmedia and colleagues explore the clinical applications of osteoanabolic therapy for osteoporosis in this #OpenAccess Review article https://t.co/XhyIyKZbCX
Read our latest economic evaluation that compares JAK inhibitors to monoclonal antibodies for treatment of moderate-to-severe atopic #dermatitis from a UK perspective.
Click the link for the full article --> https://t.co/IZIVihif7h
#healtheconomics
Nearly 700,000 hospitalizations and 110,000 deaths prevented by the #Pfizervaccine in the US. Read the full article and press release by clicking the links below:
Press release: https://t.co/ltvnAzDrr7
Article: https://t.co/yNBnrMDQJX
#COVID#COVIDVACCINE